Mankind launches drug to treat Diabetes, Heart failure

The core at Mankind Pharma is to make quality and affordable medicines accessible to the Indian citizens

Medicine Medical
Picture: Pixabay

Mankind Pharma, the fourth largest pharmaceutical company in India has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat diabetes, heart failure and chronic kidney disease.

The active pharmaceutical ingredient is procured from DMF facility approved by USFDA, EU GMP and WHO GMP, which ensures highest global efficacy and safety standards. It is believed that quality of DMF grade facility product is of highest standard in terms of safety and efficacy.

DMF (Drug Master File) is an important confidential document submitted to USFDA by a manufacturer in order to get approval for exporting pharmaceutical drugs and its ingredients to the US market.

Heart attack Heart disease Heart pain Health
Picture: Pixabay

DMF provides necessary documentation to regulatory agencies to prove that the manufacturing facility satisfies the quality and safety requirements of USFDA and other regulatory bodies across the world. USFDA ensures that the drug substance which is subject of the DMF is of the best quality.

Speaking at the launch, Atish Majumdar, president, Mankind Pharma, said, “The core at Mankind Pharma is to make quality and affordable medicines accessible to the Indian citizens.

Launching API DMF grade dapagliflozin is an innovative futuristic approach to provide the best in class quality to the patients. This is just the beginning, we are committed to adding more medicines to the list. Serving life is a mission in progress for us at Mankind Pharma.”

Cadila Pharma launches Posaconazole to treat fungal diseases

Cipla launches Vitamin C Chewable Tablets with Gold Supplement

Glenmark launches drug to treat Pulmonary disease in UK

Alkem launches Drug for Epilepsy treatment in India

Black Fungus: Mankind Pharma launches drug for treatment

Black fungus: SP Accure Labs launches Amphotericin B emulsion

Applications Forms: All types of Clinical Trials

Govt invites applications to manufacture Medical Device under PLI scheme

IPC to revise draft chapter on alternative Rapid Microbiological methods

European Commission approves Empagliflozin to treat heart failure

Synthetic Kidney can be created: Stem cell researchers

Common antibiotic useful in recovery of TB patients ?


Enter your email address:

Delivered by FeedBurner